{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:39:12Z","timestamp":1762004352248,"version":"3.44.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.ad.2011.10.002","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T08:29:52Z","timestamp":1324369792000},"page":"301-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Estudio de los polimorfismos gen\u00e9ticos de la regi\u00f3n promotora del TNF-\u03b1 en pacientes espa\u00f1oles afectos de psoriasis"],"prefix":"10.1016","volume":"103","author":[{"given":"E.","family":"Gallo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Cabaleiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Abad-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Daud\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2011.10.002_bib0005","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0001-7310(06)73482-2","article-title":"Farmacogen\u00e9tica I. Concepto, historia, objetivos y \u00e1reas de estudio","volume":"97","author":"Daud\u00e9n","year":"2006","journal-title":"Actas Demosifiliogr"},{"key":"10.1016\/j.ad.2011.10.002_bib0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00008571-199808000-00001","article-title":"Hypothesis: comparison of inter- and intra-individual variations can substitute for twin studies in drug research","volume":"8","author":"Kalow","year":"1998","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.ad.2011.10.002_bib0015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.clindermatol.2007.08.010","article-title":"The genetic basis of psoriasis","volume":"25","author":"Valdimarsson","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.ad.2011.10.002_bib0020","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/1523-1747.ep12337469","article-title":"A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis","volume":"109","author":"H\u00f6hler","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2011.10.002_bib0025","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1523-1747.1999.00654.x","article-title":"Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis","volume":"113","author":"Reich","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2011.10.002_bib0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.0022-202x.2001.01642.x","article-title":"Promoter polymorphisms of the genes encoding tumor necrosis factor-alpha and interleukin-1beta are associated with different subtypes of psoriasis characterized by early and late disease onset","volume":"118","author":"Reich","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2011.10.002_bib0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0923-1811(02)00022-1","article-title":"Lack of association of TNF-238A and -308A in Japanese patients with psoriasis vulgaris, psoriatic arthritis and generalized pustular psoriasis","volume":"29","author":"Nishibu","year":"2002","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.ad.2011.10.002_bib0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2133.2007.07993.x","article-title":"Associations of promoter region polymorphisms in the tumour necrosis factor-alpha gene and early-onset psoriasis vulgaris in a northern Polish population","volume":"157","author":"Nedoszytko","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2011.10.002_bib0045","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/art.22590","article-title":"TNF polymorphisms in psoriasis: association of psoriatic arthritis with the promoter polymorphism TNF*-857 independent of the PSORS1 risk allele","volume":"56","author":"Reich","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ad.2011.10.002_bib0050","first-page":"113","article-title":"A - 308 promoter polymorphism of tumor necrosis factor alpha gene does not associate with the susceptibility to psoriasis vulgaris. No difference either between psoriasis type I and type II patients","volume":"15","author":"Baran","year":"2006","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"10.1016\/j.ad.2011.10.002_bib0055","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.gene.6364004","article-title":"IL-10 promoter polymorphisms influence disease severity and course in psoriasis","volume":"4","author":"Kingo","year":"2003","journal-title":"Genes Immun"},{"key":"10.1016\/j.ad.2011.10.002_bib0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2340\/00015555-0427","article-title":"IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris","volume":"88","author":"Baran","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2011.10.002_bib0065","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/sj.jid.5701255","article-title":"Polymorphisms of the IL12B and IL23R genes are associated with psoriasis","volume":"128","author":"Nair","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2011.10.002_bib0070","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/jid.2008.308","article-title":"Genetic variations in cytokines and cytokine receptors associated with psoriasis found by genome-wide association","volume":"129","author":"Duffin","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2011.10.002_bib0075","first-page":"299","article-title":"Genetic variation and psoriasis","volume":"143","author":"Gudjonsson","year":"2008","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.ad.2011.10.002_bib0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cyto.2007.04.004","article-title":"TGF-beta(1) gene polymorphism in psoriasis vulgaris","volume":"38","author":"Baran","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.ad.2011.10.002_bib0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/13547500701610273","article-title":"IFN-gamma promoter gene polymorphism in psoriasis vulgaris","volume":"13","author":"Baran","year":"2008","journal-title":"Biomarkers"},{"key":"10.1016\/j.ad.2011.10.002_bib0090","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.drudis.2009.10.002","article-title":"The TNF superfamily in 2009: new pathways, new indications, and new drugs","volume":"14","author":"Tansey","year":"2009","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ad.2011.10.002_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.jidsymp.5650029","article-title":"Tumor necrosis factor blockade: mechanism of action","volume":"12","author":"Gottlieb","year":"2007","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.ad.2011.10.002_bib0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.jidsymp.5650034","article-title":"Binding characteristics of tumor necrosis factor receptor-Fc fusion proteins vs anti-tumor necrosis factor mAbs","volume":"12","author":"Kohno","year":"2007","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.ad.2011.10.002_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S146239940900129X","article-title":"Molecular pathophysiology of psoriasis and molecular targets of antipsoriatic therapy","volume":"11","author":"R\u00e1cz","year":"2009","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.ad.2011.10.002_bib0110","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.4067\/S0034-98872005000900014","article-title":"Papel de los polimorfismos -238 y -308 del promotor del factor de necrosis tumoral alfa en la patogenia y respuesta a tratamiento anti- factor de necrosis tumoral alfa en artritis reumatoide","volume":"133","author":"Llanos","year":"2005","journal-title":"Rev M\u00e9d Chile"},{"key":"10.1016\/j.ad.2011.10.002_bib0115","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/art.11168","article-title":"Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis","volume":"48","author":"Mugnier","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ad.2011.10.002_bib0120","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/03009740410005863","article-title":"Tumour necrosis factor-alpha (TNF-alpha) levels and influence of -308 TNF-alpha promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis","volume":"33","author":"Cuchacovich","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ad.2011.10.002_bib0125","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/03009740600904284","article-title":"Tumour necrosis factor (TNF)alpha -308 G\/G promoter polymorphism and TNFalpha levels correlate with a better response to adalimumab in patients with rheumatoid arthritis","volume":"35","author":"Cuchacovich","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ad.2011.10.002_bib0130","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/art.23092","article-title":"Influence of -308 A\/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritis","volume":"57","author":"Guis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ad.2011.10.002_bib0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/rheumatology\/kel175","article-title":"The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients","volume":"46","author":"Seitz","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ad.2011.10.002_bib0140","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2217\/14622416.9.2.195","article-title":"Psoriatic arthritis: genetic susceptibility and pharmacogenetics","volume":"9","author":"Rahman","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ad.2011.10.002_bib0145","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/ard.2007.074104","article-title":"A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis","volume":"67","author":"Miceli-Richard","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ad.2011.10.002_bib0150","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/rheumatology\/keh550","article-title":"The influence of a polymorphism at position -857 of the tumour necrosis factor alpha gene on clinical response to etanercept therapy in rheumatoid arthritis","volume":"44","author":"Kang","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ad.2011.10.002_bib0155","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2217\/14622416.8.7.761","article-title":"Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis","volume":"8","author":"Coenen","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ad.2011.10.002_bib0160","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2310\/JIM.0b013e318189152b","article-title":"Tumor necrosis factor \u03b1-308 and -238 polymorphisms in rheumatoid arthritis. Association with messenger RNA expression and sTNF-\u03b1","volume":"56","author":"Oreg\u00f3n-Romero","year":"2008","journal-title":"J Invest Med"},{"key":"10.1016\/j.ad.2011.10.002_bib0165","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.0022-202X.2004.23556.x","article-title":"Association of TNF\u2013238 and\u2013308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthitis but not with pustulosis palmoplantaris","volume":"124","author":"M\u00f6ssner","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2011.10.002_bib0170","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1365-4632.2010.04465.x","article-title":"Human leukocyte antigen (HLA) and single nucleotide polymorphisms (SNPs) tumor necrosis factor (TNF)-alpha and -308 as genetic markers of susceptibilitiy to psoriasis and severity of the disease in a long-term follow-up Brazilians","volume":"49","author":"Magalhaes","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2011.10.002_bib0175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00403-003-0392-9","article-title":"Polymorphisms of tumor necrosis factor (TNF) \u03b1 and \u03b2 genes in Korean patients with psoriasis","volume":"295","author":"Kim","year":"2003","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.ad.2011.10.002_bib0180","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000074117","article-title":"Lack of association between the promoter polymorphisms at positions -308 and -238 of the tumor necrosis factor alpha gene and psoriasis vulgaris in Japanese patients","volume":"207","author":"Tsunemi","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2011.10.002_bib0185","first-page":"105","article-title":"Association of cytokine gene polymorphisms with psoriasis in cases from the Nile Delta of Egypt","volume":"18","author":"Settin","year":"2009","journal-title":"Acta Dermatoven APA"},{"key":"10.1016\/j.ad.2011.10.002_bib0190","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-2133.2001.04143.x","article-title":"Cytokine gene polymorphism in psoriasis","volume":"144","author":"Craven","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2011.10.002_bib0195","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1038\/sj.jid.5700822","article-title":"TNF-alpha gene promoter -238G>A and -308G>A polymorphisms alter risk of psoriasis vulgaris: a meta-analysis","volume":"127","author":"Li","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2011.10.002_bib0200","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/ard.2005.039164","article-title":"TNF\u03b1 polymorphisms and risk of psoriatic arthritis","volume":"65","author":"Rahman","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ad.2011.10.002_bib0205","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.tpj.6500067","article-title":"Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling","volume":"1","author":"Oestreicher","year":"2001","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.ad.2011.10.002_bib0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0001-7310(07)70002-9","article-title":"Farmacogen\u00e9tica II. M\u00e9todos moleculares de estudio, bioinform\u00e1tica y aspectos \u00e9ticos","volume":"98","author":"Daud\u00e9n","year":"2007","journal-title":"Actas Dermosifiliogr"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731011004637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731011004637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:58:00Z","timestamp":1757552280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731011004637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0001731011004637"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2011.10.002","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estudio de los polimorfismos gen\u00e9ticos de la regi\u00f3n promotora del TNF-\u03b1 en pacientes espa\u00f1oles afectos de psoriasis","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2011.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Espa\u00f1a, S.L. and AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}